Increased secretion of glucagon
Billable / specific
E16.3 is a billable, specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes in FY2027.
Inclusion terms
Applicable to
- Hyperplasia of pancreatic endocrine cells with glucagon excess
Includes (from E16)
- Note: All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Excludes1
Not coded here — never report together with this code.
Also known as
- Hyperplasia of pancreatic endocrine cells with glucagon excess
- Abnormal, abnormality, abnormalities, glucagon secretion
- Abnormal, abnormality, abnormalities, secretion, glucagon
- Excess, excessive, excessively, glucagon
- Hypersecretion, glucagon
- Increase, increased, secretion, glucagon
Parent code
- E16Other disorders of pancreatic internal secretionHeader
Related codes
- E16.0Drug-induced hypoglycemia without comaBillable
- E16.1Other hypoglycemiaBillable
- E16.2Hypoglycemia, unspecifiedBillable
- E16.4Increased secretion of gastrinBillable
- E16.8Other specified disorders of pancreatic internal secretionBillable
- E16.9Disorder of pancreatic internal secretion, unspecifiedBillable
- E16.AHypoglycemia levelHeader